Literature DB >> 18472018

Effect of artemisinins and other endoperoxides on nitric oxide-related signaling pathway in RAW 264.7 mouse macrophage cells.

V Badireenath Konkimalla1, Martina Blunder, Bernhard Korn, Shahid A Soomro, Herwig Jansen, Wonsuk Chang, Gary H Posner, Rudolf Bauer, Thomas Efferth.   

Abstract

Artemisinin is the active principle of the Chinese herb Artemisia annua L. In addition to its anti-malarial activity, artemisinin and its derivatives have been shown to exert profound anti-cancer activity. The endoperoxide moiety in the chemical structure of artemisinin is thought to be responsible for the bioactivity. Here, we analyzed the cytotoxicity and the ability of artemisinin, five of its derivatives, and two other endoperoxides to inhibit generation of nitric oxide (NO). In the RAW 264.7 mouse macrophage cell line, the well-established model cell line to analyze NO generation, artesunate revealed the highest ability to inhibit NO production among all compounds tested. In cytotoxicity assays (XTT assay), the IC(50) value of RAW 264.7 cells for artesunate was determined to be 3.1+/-0.7 microM. In order to associate the cytotoxic effects with specific alteration in gene expression related to NO metabolism and signaling, whole genome mRNA microarray analyses were conducted. RAW 264.7 cells were treated with artesunate using DMSO as vehicle control followed by microarray analysis. A total of 36 genes related to NO metabolism and signaling were found to be differentially expressed upon exposure to artesunate. Apart from NO-related genes, the expression of genes associated with other functional groups was also analyzed. Out of 24 functional groups, differential expression was most prominent in genes involved in cell-to-cell signaling and interactions. Further refinement of this analysis showed that the pathways for cAMP-mediated signaling and Wnt/beta-catenin signaling were most closely related to changes in mRNA expression. In conclusion, NO generation and signaling play a role in exhibiting cytotoxic activity of artesunate. In addition, other signaling pathways also contribute to the inhibitory effect of artesunate towards RAW 264.7 cells pointing to a multi-factorial mode of action of artesunate.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18472018      PMCID: PMC2582405          DOI: 10.1016/j.niox.2008.04.008

Source DB:  PubMed          Journal:  Nitric Oxide        ISSN: 1089-8603            Impact factor:   4.427


  58 in total

Review 1.  The biphasic nature of nitric oxide responses in tumor biology.

Authors:  Lisa A Ridnour; Douglas D Thomas; Sonia Donzelli; Michael G Espey; David D Roberts; David A Wink; Jeffrey S Isenberg
Journal:  Antioxid Redox Signal       Date:  2006 Jul-Aug       Impact factor: 8.401

2.  Nitric oxide upregulates expression of DNA-PKcs to protect cells from DNA-damaging anti-tumour agents.

Authors:  W Xu; L Liu; G C Smith; l G Charles
Journal:  Nat Cell Biol       Date:  2000-06       Impact factor: 28.824

Review 3.  Colorectal cancer and genetic alterations in the Wnt pathway.

Authors:  S Segditsas; I Tomlinson
Journal:  Oncogene       Date:  2006-12-04       Impact factor: 9.867

4.  The anti-malarial artesunate is also active against cancer.

Authors:  T Efferth; H Dunstan; A Sauerbrey; H Miyachi; C R Chitambar
Journal:  Int J Oncol       Date:  2001-04       Impact factor: 5.650

5.  Chemosensitization of cancer in vitro and in vivo by nitric oxide signaling.

Authors:  Lisa J Frederiksen; Richard Sullivan; Lori R Maxwell; Shannyn K Macdonald-Goodfellow; Michael A Adams; Brian M Bennett; D Robert Siemens; Charles H Graham
Journal:  Clin Cancer Res       Date:  2007-04-01       Impact factor: 12.531

6.  Inhibition of inducible nitric oxide synthase enhances anti-tumour immune responses in rats immunized with IFN-gamma-secreting glioma cells.

Authors:  W Badn; P Hegardt; M A Fellert; A Darabi; M Esbjörnsson; K E Smith; S Janelidze; L G Salford; E Visse; P Siesjö
Journal:  Scand J Immunol       Date:  2007-03       Impact factor: 3.487

Review 7.  Willmar Schwabe Award 2006: antiplasmodial and antitumor activity of artemisinin--from bench to bedside.

Authors:  Thomas Efferth
Journal:  Planta Med       Date:  2007-03-12       Impact factor: 3.352

Review 8.  Nitrosative stress in cancer therapy.

Authors:  David G Hirst; Tracy Robson
Journal:  Front Biosci       Date:  2007-05-01

9.  Artesunate attenuates the growth of human colorectal carcinoma and inhibits hyperactive Wnt/beta-catenin pathway.

Authors:  Lin-Na Li; Hua-Dong Zhang; Shou-Jun Yuan; Zeng-Yue Tian; Lin Wang; Zhi-Xian Sun
Journal:  Int J Cancer       Date:  2007-09-15       Impact factor: 7.396

10.  Role of transferrin receptor and the ABC transporters ABCB6 and ABCB7 for resistance and differentiation of tumor cells towards artesunate.

Authors:  Gerhard Kelter; Daniel Steinbach; Venkata Badireenath Konkimalla; Tsuyoshi Tahara; Shigeru Taketani; Heinz-Herbert Fiebig; Thomas Efferth
Journal:  PLoS One       Date:  2007-08-29       Impact factor: 3.240

View more
  22 in total

1.  Induction of Apoptosis in Human Breast Cancer MCF-7 Cells by a Semi-Synthetic Derivative of Artemisinin: A Caspase-Related Mechanism.

Authors:  Leila Jamalzadeh; Hossein Ghafoori; Mahmoodreza Aghamaali; Reyhaneh Sariri
Journal:  Iran J Biotechnol       Date:  2017-09-27       Impact factor: 1.671

2.  Effect of Artemisia annua extract on treating active rheumatoid arthritis: A randomized controlled trial.

Authors:  Min Yang; Ming-Yang Guo; Yong Luo; Ming-Dong Yun; Jiao Yan; Tao Liu; Chang-Hong Xiao
Journal:  Chin J Integr Med       Date:  2016-12-29       Impact factor: 1.978

3.  Artemisinin analogue SM934 ameliorates the proteinuria and renal fibrosis in rat experimental membranous nephropathy.

Authors:  Tian-tian Li; Xiao-hui Zhang; Jing-feng Jing; Xin Li; Xiao-qian Yang; Feng-hua Zhu; Wei Tang; Jian-ping Zuo
Journal:  Acta Pharmacol Sin       Date:  2015-01-26       Impact factor: 6.150

4.  Synthesis of N-substituted 2-[(1E)-alkenyl]-4-(1H)-quinolone derivatives as antimycobacterial agents against non-tubercular mycobacteria.

Authors:  Abraham A Wube; Franz Bucar; Christina Hochfellner; Martina Blunder; Rudolf Bauer; Antje Hüfner
Journal:  Eur J Med Chem       Date:  2011-03-03       Impact factor: 6.514

5.  An artemisinin-derived dimer has highly potent anti-cytomegalovirus (CMV) and anti-cancer activities.

Authors:  Ran He; Bryan T Mott; Andrew S Rosenthal; Douglas T Genna; Gary H Posner; Ravit Arav-Boger
Journal:  PLoS One       Date:  2011-08-31       Impact factor: 3.240

6.  Design, synthesis and antimycobacterial activities of 1-methyl-2-alkenyl-4(1H)-quinolones.

Authors:  Abraham A Wube; Antje Hüfner; Christina Thomaschitz; Martina Blunder; Manfred Kollroser; Rudolf Bauer; Franz Bucar
Journal:  Bioorg Med Chem       Date:  2010-11-03       Impact factor: 3.641

7.  Artemisinin analogue SM934 ameliorates murine experimental autoimmune encephalomyelitis through enhancing the expansion and functions of regulatory T cell.

Authors:  Xin Li; Tian-Tian Li; Xiao-Hui Zhang; Li-Fei Hou; Xiao-Qian Yang; Feng-Hua Zhu; Wei Tang; Jian-Ping Zuo
Journal:  PLoS One       Date:  2013-08-29       Impact factor: 3.240

8.  Treatment of Iron-Loaded Veterinary Sarcoma by Artemisia annua.

Authors:  Elmar Breuer; Thomas Efferth
Journal:  Nat Prod Bioprospect       Date:  2014-04-12

9.  Systems biology of meridians, acupoints, and chinese herbs in disease.

Authors:  Li-Ling Lin; Ya-Hui Wang; Chi-Yu Lai; Chan-Lao Chau; Guan-Chin Su; Chun-Yi Yang; Shu-Ying Lou; Szu-Kai Chen; Kuan-Hao Hsu; Yen-Ling Lai; Wei-Ming Wu; Jian-Long Huang; Chih-Hsin Liao; Hsueh-Fen Juan
Journal:  Evid Based Complement Alternat Med       Date:  2012-10-18       Impact factor: 2.629

10.  Effects of Scrophularia ningpoensis Hemsl. on Inhibition of Proliferation, Apoptosis Induction and NF-κB Signaling of Immortalized and Cancer Cell Lines.

Authors:  Xiao Shen; Tolga Eichhorn; Henry Johannes Greten; Thomas Efferth
Journal:  Pharmaceuticals (Basel)       Date:  2012-02-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.